Medibank Private Limited (ASX:MPL)
Australia · Delayed Price · Currency is AUD | Market Cap | 13.25B +2.3% |
| Revenue (ttm) | 8.77B +5.2% |
| Net Income | 463.40M -5.4% |
| EPS | 0.17 -5.5% |
| Shares Out | 2.75B |
| PE Ratio | 28.63 |
| Forward PE | 19.80 |
| Dividend | 0.18 (3.74%) |
| Ex-Dividend Date | Feb 26, 2026 |
| Volume | 10,501,910 |
| Average Volume | 6,394,081 |
| Open | 4.830 |
| Previous Close | 4.850 |
| Day's Range | 4.800 - 4.880 |
| 52-Week Range | 4.060 - 5.310 |
| Beta | 0.05 |
| RSI | 64.16 |
| Earnings Date | Aug 20, 2026 |
About Medibank Private
Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance products to overseas visitors and students. The Medibank Health segment ... [Read more]
Financial Performance
In fiscal year 2025, Medibank Private's revenue was 8.56 billion, an increase of 6.56% compared to the previous year's 8.03 billion. Earnings were 500.80 million, an increase of 1.69%.
Financial StatementsNews
Top 10 Companies with Highest Employee Retention in Australia 2026: Medibank Leads as Retention Kings
SYDNEY — In a year when Australia's average employee turnover hovers around 16% and one in three businesses battles rates above 20%, a select group of employers is defying the odds with retention rate...
Medibank Private Earnings Call Transcript: H1 2026
Strong half-year results driven by growth in health insurance and Medibank Health, supported by the Better Medical acquisition and increased customer engagement. Stable margins, robust capital position, and a positive outlook for FY 2026 underpin continued investment and dividend growth.
Medibank Private Quarterly report: H1 2026
Medibank Private has published its H1 2026 quarterly earnings report on February 18, 2026.
Medibank Private Slides: H1 2026
Medibank Private has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 18, 2026.
Medibank Private Transcript: AGM 2025
The meeting highlighted strong financial growth, increased dividends, and major investments in mental health and primary care. Board renewal, diversity, and sustainability were emphasized, with shareholders engaging on costs, AI, and governance. Voting supported all resolutions.
Medibank Private Transcript: Status Update
Aspirations include growing health segment earnings to at least AUD 200 million by FY 2030, doubling engagement to 10 million people, and expanding digital and preventative care. Technology, partnerships, and disciplined investment underpin growth, with a focus on system reform and value creation.
Medibank Private Slides: Status Update
Medibank Private has posted slides in relation to its latest quarterly earnings report, which was published on October 28, 2025.
Medibank Private Earnings Call Transcript: H2 2025
Group operating profit rose 8.9% to $762.4 million, with strong growth in both resident and non-resident health insurance and a 27% increase in Medibank Health segment profit. Management expects stable margins, continued disciplined growth, and further M&A investment in FY 2026.
Medibank Private Annual report: H2 2025
Medibank Private has published its H2 2025 annual report on August 27, 2025.
Medibank Private Slides: H2 2025
Medibank Private has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 27, 2025.
Medibank Private Press release: Trading Update
Medibank Private issued a press release on May 5, 2025, disclosing material business information to investors.
Medibank Private Earnings Call Transcript: H1 2025
Strong financial performance with double-digit profit growth, robust capital position, and continued investment in customer value, digital health, and M&A. Outlook includes disciplined cost management, targeted policyholder growth, and finalization of COVID Give-Backs.
Medibank Private Quarterly report: H1 2025
Medibank Private has published its H1 2025 quarterly earnings report on February 26, 2025.
Medibank Private Slides: H1 2025
Medibank Private has posted slides in relation to its H1 2025 quarterly earnings report, which was published on February 26, 2025.
Medibank Private Transcript: AGM 2024
The meeting highlighted strong financial growth, increased dividends, and ongoing investment in digital health and sustainability. Shareholders approved all resolutions, with discussions on board diversity, executive pay, and customer value. Key risks include healthcare inflation and cybersecurity.
Medibank: Australian healthcare pivoting to homebased and preventative care
David Koczkar, CEO of Medibank discusses the shifting Australian healthcare landscape and the health insurer's focus on innovation investment.
Medibank Private Earnings Call Transcript: H2 2024
Solid FY 2024 results with strong profit growth, disciplined market share strategy, and robust capital position. Continued investment in health services, digital innovation, and M&A supports long-term growth, while customer givebacks and productivity savings remain priorities.
Medibank Private Annual report: H2 2024
Medibank Private has published its H2 2024 annual report on August 21, 2024.
Medibank Private Slides: H2 2024
Medibank Private has posted slides in relation to its H2 2024 quarterly earnings report, which was published on August 21, 2024.
Medibank Private Earnings Call Transcript: H1 2024
Medibank Private Quarterly report: H1 2024
Medibank Private has published its H1 2024 quarterly earnings report on February 21, 2024.
Medibank Private Slides: H1 2024
Medibank Private has posted slides in relation to its H1 2024 quarterly earnings report, which was published on February 21, 2024.
Medibank Private upgraded to Buy from Hold at Jefferies
Jefferies upgraded Medibank Private to Buy from Hold with an unchanged price target of A$4. Medibank previously affirmed FY24 guidance for resident policyholder growth and underlying claims, notes the...
Medibank Private Transcript: AGM 2023
Medibank CEO says remediation was the focus for FY23 after last year's cyber attack
David Koczkar, CEO of Medibank, discusses the fallout of last year's cyber attack on the insurer, and how it is looking to integrate generative AI into the business.